NCT06574620 2026-01-16
ACCELERATE
British Columbia Cancer Agency
Phase NA Recruiting
Clinical Trials
12 trialsNCT06635980 2025-12-12
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
Mayo Clinic
Phase 2 Recruiting
NCT04323202 2025-10-24
Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N
Case Comprehensive Cancer Center
Phase 1 Completed
NCT04239040 2025-03-19
GVAX Plus Checkpoint Blockade in Neuroblastoma
Dana-Farber Cancer Institute
Phase 1 Terminated
NCT03735745 2025-01-30
Transdisciplinary Oral/Oropharyngeal Cancer Research & Care in Head and Neck Cancer (TORCH)
Medical University of South Carolina
Phase NA Completed
NCT06385288 2024-12-06
Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas
University Hospital Tuebingen
Phase NA Recruiting
NCT04223102 2023-08-02
Microbiome and Rectal Cancer
University of South Florida
Phase NA Active not recruiting
NCT00298064 2023-07-05
Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer
University of New Mexico
Phase NA Withdrawn
NCT05348161 2022-04-27
Dynamic Multiomics Evaluation of Anti-HER2 and Immunotherapy in HER2 Positive Gastric Cancer
Peking University
Phase NA Unknown
NCT02441140 2020-05-04
Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis
Dana-Farber Cancer Institute
Phase NA Terminated
NCT01302002 2016-02-23
The Use of Metformin in Early Breast Cancer Patients Pre-Surgery
Instituto Nacional de Cancer, Brazil
Phase EARLY_PHASE1 Withdrawn
NCT00228683 2013-11-26
Hepatoblastoma Biology Study and Tissue Bank
Emory University
Phase NA Withdrawn